logo

For the Inventor, By the Inventor

Suwon, South Korea

So-jung Park

This inventor holds 7 USPTO granted patents. Top assignee: Cj Cheiljedang Corporation. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: So-jung Park. Retrieved from https://idiyas.com/inventor/so-jung-park-yacvtggy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:

goldMedal7 out of 978 
 
Cj Cheiljedang Corporation
 patents

Years Active: 2021-2025

Loading Chart...
7 patents (USPTO):Explore Patents
1. 12269851 - Polypeptide and method of producing IMP using the same (2025-04-08),
2. 11746130 - Polypeptide and method of producing IMP using the same (2023-09-05),
3. 11697810 - Adenylosuccinate synthetase and method for producing purine nucleotides using the same (2023-07-11),
4. 11384124 - Polypeptide and method of producing IMP using the same (2022-07-12),
5. 11236321 - Adenylosuccinate synthetase and method for producing purine nucleotides using the same (2022-02-01),
6. 11066687 - 5'-inosinic acid dehydrogenase and method of preparing 5′-inosinic acid using the same (2021-07-20),
7. 11008599 - Variant phosphoribosylpyrophosphate amidotransferase and method of preparing purine nucleotide using the same (2021-05-18),

Title: So-jung Park: Innovator in Polypeptide Production

Introduction

So-jung Park is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of 5'-inosine monophosphate (IMP). With a total of seven patents to his name, Park's work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest patents, Park has developed a novel protein variant that exhibits the ability to export 5'-inosine monophosphate. This innovation includes a microorganism that comprises the protein variant and a method for preparing 5'-inosine monophosphate using this microorganism. His work in this area is crucial for advancing biotechnological applications and improving production efficiency.

Career Highlights

So-jung Park is currently employed at CJ Cheiljedang Corporation, a leading company in the food and biotechnology sectors. His role at the company allows him to apply his innovative ideas and research findings to real-world applications, contributing to the company's success and growth.

Collaborations

Park collaborates with talented coworkers, including Min Ji Baek and Ji Hye Lee. Their combined expertise fosters a creative environment that enhances the development of new technologies and solutions in their field.

Conclusion

In summary, So-jung Park is a notable inventor whose work in polypeptide production and biotechnology has made a significant impact. His innovative patents and collaborations continue to drive advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…